Public Sector Pension Investment Board (PSP Investments)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-264,800	Closed	-$2.01M	–	1350
2025 Q3	$2.01M	Buy	+264,800	New	+$2.2M	0.01%	1115
2020 Q1	–	Sell	-48,801	Closed	-$168K	–	1345
2019 Q4	$168K	Sell	48,801 -369,899	-88%	-$931K	﹤0.01%	1524
2019 Q3	$1.2M	Buy	+418,700	New	+$1.3M	0.01%	1236

Other funds holding BCRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s BCRX Position: Q4 2025 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of BioCryst Pharmaceuticals (BCRX) in Q4 2025, closing a stake of 264,800 shares — an estimated $2.01M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in BCRX in Q3 2019 and held it in 3 quarters. The position peaked at $2.01M in Q3 2025. 272 funds tracked by Wall St. Rank hold BCRX as of Q4 2025.

Public Sector Pension Investment Board (PSP Investments) reported no remaining BioCryst Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Public Sector Pension Investment Board (PSP Investments) sold 264,800 BioCryst Pharmaceuticals shares in Q4 2025, an estimated $2.01M.
Public Sector Pension Investment Board (PSP Investments) first reported a position in BioCryst Pharmaceuticals in Q3 2019 and held it in 3 quarters.
Public Sector Pension Investment Board (PSP Investments)'s BioCryst Pharmaceuticals position peaked at $2.01M in Q3 2025.
272 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q4 2025.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q4 2025, filed 13 Feb 2026.